首页 › 自身免疫性疾病 › 北卡罗来纳州 › Durham
Durham NC 自身免疫性疾病临床试验
15项针对 自身免疫性疾病的研究正在 Durham及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Environmental Risk Factors for the Anti-synthetase Syndrome
招募中观察性研究欢迎健康志愿者
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 距离 7 英里
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Duke University Hospital, Durham
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
招募中2/3 期
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill · 距离 10 英里
Daratumumab in Primary Antiphospholipid Syndrome
招募中1/2 期
- Duke University, Durham
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
招募中1 期
- Duke University Medical Center, Durham
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Duke University Hospital, Durham
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
招募中3 期
- GSK Investigational Site, Durham
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
招募中1/2 期
- UNC Chapel Hill, Chapel Hill · 距离 10 英里
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
招募中2/3 期
- Duke University, Durham
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
招募中3 期
- Duke University Medical Center, Durham
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
招募中3 期
- Site Number - 1013, Durham
- Site Number - 1020, Chapel Hill · 距离 10 英里
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
招募中1 期
- Duke University, Durham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中观察性研究
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 距离 10 英里
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
招募中1 期
- Duke University Health System, Durham
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
招募中观察性研究欢迎健康志愿者
- Duke University, Durham
其他城市的 自身免疫性疾病试验
- Houston, TX21 项研究
- Washington, DC19 项研究
- New York City, NY19 项研究
- Philadelphia, PA16 项研究
- Boston, MA13 项研究
- Los Angeles, CA12 项研究
- Chicago, IL12 项研究
- Dallas, TX9 项研究
- Cleveland, OH8 项研究
- Atlanta, GA8 项研究
- Milwaukee, WI8 项研究
- Portland, OR8 项研究
Durham的其他研究
- 乳腺癌63 项研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌39 项研究
- 多发性骨髓瘤37 项研究
- 转移性癌症33 项研究
- 急性髓系白血病33 项研究
- 肺癌32 项研究
- 前列腺癌32 项研究
- 结直肠癌28 项研究
- 慢性淋巴细胞白血病27 项研究
- 卵巢癌27 项研究
- 心力衰竭26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。